Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Tai-Ze Yuan"'
Autor:
Ze-Jiang Zhan, Wen-Yu Yao, Fang Zhang, Wen-Ze Qiu, Kai- Liao, Jian-Hui Feng, Jin-Yun Tan, Hui Liu, Tai-Ze Yuan, Rong-Hui Zheng, Ya-Wei Yuan
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundThe optimal second-line systemic treatment model for recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC) remains controversial. A Bayesian network meta-analysis (NMA) was performed to address this issue with regard
Externí odkaz:
https://doaj.org/article/a7a9fb44ce8a4ac6aab708bf08210b98
Publikováno v:
Thoracic Cancer, Vol 10, Iss 12, Pp 2195-2199 (2019)
Externí odkaz:
https://doaj.org/article/03ee82e1a2e14957aef82591aa5cde8b
Publikováno v:
Cancer Communications, Vol 39, Iss 1, Pp 1-7 (2019)
Abstract Proton therapy offers dominant advantages over photon therapy due to the unique depth-dose characteristics of proton, which can cause a dramatic reduction in normal tissue doses both distal and proximal to the tumor target volume. In turn, t
Externí odkaz:
https://doaj.org/article/ea0d1b31c06c4a63803a46880a589819
Publikováno v:
Journal of Cancer
Objective: To investigate the clinical value of induction chemotherapy (IC) with docetaxel plus cisplatin (TP) followed by concurrent chemoradiotherapy (CCRT) with TP in locoregionally advanced nasopharyngeal carcinoma (NPC). Methods: A total of 544
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fbbb6766ce0f21beb38ca2088559cf5
https://doi.org/10.7150/jca.49944
https://doi.org/10.7150/jca.49944
Autor:
Ze-Jiang Zhan, Rui-Xin Zhang, Wen-Ze Qiu, Guo Li, Tai-Ze Yuan, Zhong-Yuan Liu, Kai Liao, Ya-Wei Yuan, Hao-Yun Tao, Rong-Hui Zheng
Publikováno v:
Journal of Cancer
Aims: This study aimed to investigate the clinical value of induction chemotherapy (IC) with docetaxel, 5-fluorouracil plus nedaplatin followed by concurrent chemoradiotherapy (CCRT) with nedaplatin for locoregional advanced nasopharyngeal carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49e7b99c29039f0637eae3b0a99f4766
https://doi.org/10.7150/jca.47090
https://doi.org/10.7150/jca.47090
Publikováno v:
Thoracic Cancer, Vol 10, Iss 12, Pp 2195-2199 (2019)
Thoracic Cancer
Thoracic Cancer
The role of radiotherapy in the management of cancer is well established. During the whole course of cancer treatment, more than 50% of all cancer patients need to undergo radiotherapy, which is always considered to be one curative treatment modality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce441966e1241d2e3a47af5b3e8b80d5
https://doi.org/10.1111/1759-7714.13232
https://doi.org/10.1111/1759-7714.13232
Autor:
Wang-Zhong Li, Xing Lv, Dan Hu, Shu-Hui Lv, Guo-Ying Liu, Hu Liang, Yan-Fang Ye, Wen Yang, Han-Xiong Zhang, Tai-Ze Yuan, De-Shen Wang, Nian Lu, Liang-Ru Ke, Wu-Bing Tang, Li-Hua Tong, Zhi-Jie Chen, Ting Liu, Ka-Jia Cao, Hao-Yuan Mo, Ling Guo, Chong Zhao, Ming-Yuan Chen, Qiu-Yan Chen, Pei-Yu Huang, Rui Sun, Fang Qiu, Dong-Hua Luo, Lin Wang, Yi-Jun Hua, Lin-Quan Tang, Chao-Nan Qian, Hai-Qiang Mai, Xiang Guo, Yan-Qun Xiang, Wei-Xiong Xia
Publikováno v:
JAMA Oncology. 8:706
Induction chemotherapy added to concurrent chemoradiotherapy significantly improves survival for patients with locoregionally advanced nasopharyngeal carcinoma, but the optimal induction regimen remains unclear.To determine whether induction chemothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfa635fdd019b21466786eb962a3bee4
https://doi.org/10.1001/jamaoncol.2022.0122
https://doi.org/10.1001/jamaoncol.2022.0122
Autor:
TAI-ZE YUAN1,2, HUAN-HUAN ZHANG1,2, XIAO-LING LIN3, JIN-XIU YU1,2, QIU-XIANG YANG1,2, YIN LIANG1,2, JIN DENG1,2, LAI-JI HUANG1,2, XIU-PING ZHANG1,2 xiupingzhang67@163.com
Publikováno v:
Molecular Medicine Reports. Apr2017, Vol. 15 Issue 4, p2223-2228. 6p.
Autor:
Jin Deng, Yin Liang, Tai‑Ze Yuan, Jin‑Xiu Yu, Huan‑Huan Zhang, Xiu‑Ping Zhang, Xiao‑Ling Lin, Qiu‑Xiang Yang, Lai‑Ji Huang
Publikováno v:
Molecular Medicine Reports. 15:2223-2228
Multidrug resistance (MDR) is a major clinical obstacle in the successful treatment of patients with metastatic nasopharyngeal carcinoma (NPC). Results from previous studies suggest that microRNAs (miRNA) may be involved in promoting MDR in multiple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e282b00441e003bd478c8deb6ad58891
https://doi.org/10.3892/mmr.2017.6233
https://doi.org/10.3892/mmr.2017.6233